Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Nutrition

Association of oxidative stress biomarkers with adiposity and clinical staging in women with breast cancer

Abstract

Background/Objectives:

Breast cancer is a disease characterised by both oxidative reactions and inflammation. However, few studies have focused on the oxidative and inflammatory biomarkers. The aim of the present study was to evaluate the association between oxidative stress markers and adiposity and clinical staging, as well as the association between the oxidative and the antioxidant biomarkers of women with breast cancer.

Subjects/Methods:

A total of 135 cases of breast cancer occurring in 2011 and 2012 were assessed. After exclusions, 101 pre- and post-menopausal women with clinical staging I to IV were eligible to participate in the study. The anthropometric evaluation was performed by collecting data on waist circumference, body mass index and body composition. The socioeconomic and clinical profiles were determined using a standard questionnaire. For the oxidative biomarkers, thiobarbituric acid reactive substances (TBARS), oxidative DNA damage (8-hydroxy-2-deoxyguanosine (8-OHdG)), low-density lipoprotein(−) (LDL(−)), autoantibody anti-LDL(−) and liposoluble antioxidants (α-tocopherol, retinol and β-carotene) were analysed. The data were analysed using differences in the mean values, correlation tests and multiple linear regression.

Results:

The antioxidant levels were higher in postmenopausal women with clinical staging I and II and negative lymph nodes. The TBARS level was associated with clinical staging. Adiposity was associated with levels of retinol and 8-OHdG, whereas LDL(−), 8-OHdG and TBARS were correlated with liposoluble antioxidants after adjusting for the confounders.

Conclusions:

The adiposity and clinical staging of patients were associated with oxidative stress. The oxidative and antioxidant biomarkers showed a negative correlation in patients with breast cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. American Institute for Cancer Research (AICR). World Cancer Research Fund Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR: : Washington, DC, USA, 2007.

  2. Siegel R, Jiemin M, Zhaohui Z, Ahmedin J . Cancer statistics 2014 CA Cancer J. Clin. 64: 9–29.

    Article  Google Scholar 

  3. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2014: Incidência de Câncer no Brasil. INCA, Rio de Janeiro, Brazil, 2014. Available at http://www.inca.gov.br/estimativa/2014/.

  4. Ramírez-Expósito MJ, Sánchez-López E, Cueto-Ureña C, Dueñas B, Carrera-González P, Navarro-Cecilia J et al. Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy. Exp Gerontol 2014; 58C: 34–42.

    Article  Google Scholar 

  5. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB . Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603–1616.

    Article  CAS  Google Scholar 

  6. Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, Lorente JÁ et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 2011; 80: 347–368.

    Article  Google Scholar 

  7. Yeon J-Y, Suh Y-J, Kim S-W, Baik H-W, Sung C-J, Kim H-S et al. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition 2011; 27: 912–918.

    Article  CAS  Google Scholar 

  8. Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, Oresic M et al. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res 2012; 72: 5712–5720.

    Article  CAS  Google Scholar 

  9. Thomson CA, Stendell-Hollis NR, Rock CL, Cussler EC, Flatt SW, Pierce JP . Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 2008–2015.

    Article  CAS  Google Scholar 

  10. Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P . 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer 2010; 102: 1018–1023.

    Article  CAS  Google Scholar 

  11. Pande D, Negi R, Karki K, Khanna S, Khanna RS, Khanna H . Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res 2012; 160: 411–418.

    Article  CAS  Google Scholar 

  12. Hursting SD, Dunlap SM . Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann NY Acad Sci 2012; 1271: 82–87.

    Article  CAS  Google Scholar 

  13. Kumaraguruparan R, Kabalimoorthy J, Nagini S . Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 2005; 38: 154–158.

    Article  CAS  Google Scholar 

  14. Pansini F, Cervellati C, Guariento A, Stacchini MA, Castaldini C, Bernardi A et al. Oxidative stress, body fat composition, and endocrine status in pre-and postmenopausal women. Menopause 2008; 15: 112–118.

    Article  Google Scholar 

  15. Badid N, Ahmed FZB, Merzouk H, Belbraouet S, Mokhtari N, Merzouk SA et al. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 2010; 16: 159–167.

    Article  CAS  Google Scholar 

  16. Panis C, Victorino V, Herrera A, Freitas L, De Rossi T, Campos F et al. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat 2012; 133: 881–888.

    Article  CAS  Google Scholar 

  17. Victorino V, Panis C, Campos F, Cayres R, Colado-Simão A, Oliveira S et al. Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women. Age 2012; 35: 1–11.

    Google Scholar 

  18. Karnofsky DA, Burchenal JH The clinical evaluation of chemotherapeutic agents in cancerIn: MacLeod CM (ed) Evaluation of Chemotherapeutic Agents. Columbia University Press: New York, NY, USA, 1949 pp 191–205.

    Google Scholar 

  19. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W et al. Stages of reproductive aging workshop (STRAW). J Womens Health Gend Based Med 2001; 10: 843–848.

    Article  CAS  Google Scholar 

  20. Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF . Cigarette smoking—United States, 1965–2008. MMWR Surveill Summ 2011; 60: 109–113.

    Google Scholar 

  21. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA et al. Diet and lifestyle recommendations revision 2006A scientific statement from the American Heart Association nutrition committee. Circulation 2006; 114: 82–96.

    Article  Google Scholar 

  22. World Health Organization Obesity: Preventing and Managing the GLOBAL Epidemic: Report of a WHO Consultation on Obesity, Geneva, 3–5 June 1997. World Health Organization: Geneva, Switzerland, 1998. Report no. WHO/NUT/NCD/98.1.

  23. Lipschitz DA . Screening for nutritional status in the elderly. Prim Care 1994; 21: 55–67.

    CAS  PubMed  Google Scholar 

  24. Lohman TG . Advances in Body Composition Assessment. Human Kinetics Publishers: Champaigne, IL, USA: Champaigne, IL, USA, 1992 pp 80.

    Google Scholar 

  25. Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K . Methods for testing antioxidant activity. Analyst 2002; 127: 183–198.

    Article  CAS  Google Scholar 

  26. Faulin S, do Espirito T, de Sena KCM, Rodrigues Telles AE, de Mattos Grosso D, Bernardi Faulin EJ et al. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein. Clin Chem Lab Med 2008; 46: 1769–1775.

    CAS  Google Scholar 

  27. Santo Faulin TdE, de Sena-Evangelista KCM, Pacheco DB, Augusto EM, Abdalla DSP . Development of immunoassays for anti-electronegative LDL autoantibodies and immune complexes. Clin Chim Acta 2012; 413: 291–297.

    Article  Google Scholar 

  28. Okoh V, Deoraj A, Roy D . Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta 2011; 1815: 115–133.

    CAS  PubMed  Google Scholar 

  29. Fussell KC, Udasin RG, Smith PJ, Gallo MA, Laskin JD . Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells. Carcinogenesis 2011; 32: 1285–1293.

    Article  CAS  Google Scholar 

  30. Žitnanová I, Rakovan M, Paduchová Z, Dvoráková M, Andrezálová L, Muchová J et al. Oxidative stress in women with perimenopausal symptoms. Menopause 2011; 18: 1249–1255.

    Article  Google Scholar 

  31. Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Correa-Muñoz E, Mendoza-Núñez VM . Menopause as risk factor for oxidative stress. Menopause 2012; 19: 361–367.

    Article  Google Scholar 

  32. Pande D, Karki K, Negi R, Khanna S, Khanna RS, Khanna H . NF-κB p65 subunit DNA-binding activity: association with depleted antioxidant levels in breast carcinoma patients. Cell Biochem Biophys 2013; 67: 1–7.

    Article  Google Scholar 

  33. Şener DE, Gönenç A, Akıncı M, Torun M . Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct 2007; 25: 377–382.

    Article  Google Scholar 

  34. Silva IT, Mello A, Sanches L, Abdalla D, Damasceno N . Is plasma alpha-tocopherol associated with electronegative LDL in obese adolescents? J Nutr Sci Vitaminol 2012; 59: 100–107.

    Article  Google Scholar 

  35. Mafra D, Santos FR, Lobo JC, de Mattos Grosso D, Barreira AL, LGC Velarde et al. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL (−)] in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1587–1592.

    Article  CAS  Google Scholar 

  36. Pereira EC, Bertolami MC, Faludi AA, Sevanian A, Abdalla DS . Antioxidant effect of simvastatin is not enhanced by its association with α-tocopherol in hypercholesterolemic patients. Free Radic Biol Med 2004; 37: 1440–1448.

    Article  CAS  Google Scholar 

  37. Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A . Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 2007; 40: 1129–1134.

    Article  CAS  Google Scholar 

  38. Khaidakov M, Mehta JL . Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21. PLoS One 2012; 7: e46973.

    Article  CAS  Google Scholar 

  39. Avogaro P, Bon GB, Cazzolato G . Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79–87.

    Article  CAS  Google Scholar 

  40. Estruch M, Sánchez-Quesada JL, Ordóñez Llanos J, Benítez S . Electronegative LDL: a circulating modified LDL with a role in inflammation. Mediators Inflamm 2013; 2013: 181324.

    Article  Google Scholar 

  41. Mello APQ, da Silva IT, Abdalla DSP, Damasceno NRT . Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 2011; 215: 257–265.

    Article  CAS  Google Scholar 

  42. Macciò A, Madeddu C . Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Sci World J 2011; 11: 2020–2036.

    Article  Google Scholar 

  43. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S et al. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol 2003; 158: 1–13.

    Article  Google Scholar 

  44. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham S . Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 2009; 125: 507–525.

    Article  Google Scholar 

  45. Pollard J, Wild CP, White KL, Greenwood DC, Cade JE, Kirk SF . Comparison of plasma biomarkers with dietary assessment methods for fruit and vegetable intake. Eur J Clin Nutr 2003; 57: 988–998.

    Article  CAS  Google Scholar 

  46. Keogh RH, White IR, Rodwell SA . Using surrogate biomarkers to improve measurement error models in nutritional epidemiology. Stat Med 2013; 32: 3838–3861.

    Article  Google Scholar 

  47. Hodge AM, Simpson JA, Fridman M, Rowley K, English DR, Giles GG et al. Evaluation of an FFQ for assessment of antioxidant intake using plasma biomarkers in an ethnically diverse population. Public Health Nutr 2009; 12: 2438–2447.

    Article  Google Scholar 

  48. Wang Y, Yang M, Lee SG, Davis CG, Koo SI, Chun OK . Dietary total antioxidant capacity is associated with diet and plasma antioxidant status in healthy young adults. J Acad Nutr Diet 2012; 112: 1626–1635.

    Article  CAS  Google Scholar 

  49. Frankenfeld CL, Lampe JW, Shannon J, Gao DL, Li W, Ray RM et al Fruit and vegetable intakes in relation to plasma nutrient concentrations in women in Shanghai Public Health Nutr 2012; 15: 167–175.

Download references

Acknowledgements

This study was supported, in part, by the Sao Paulo Research Foundation (FAPESP), Brazil (grant 2010/19207-6; 2011/15590-2) and also, in part, by FAPESP process: 2010/19207-6; 2011/15590-2.

Author Contributions

AAFC performed data analysis and drafted the manuscript. SMMLV was involved in data collection and analysis. LAL, MdRDdOL, PHdCR and THPE were involved in data analysis and critical analysis. NRTD performed data analysis and final revision and critical analysis of the manuscript. All authors read and approved the final draft of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N R T Damasceno.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carioca, A., Verde, S., Luzia, L. et al. Association of oxidative stress biomarkers with adiposity and clinical staging in women with breast cancer. Eur J Clin Nutr 69, 1256–1261 (2015). https://doi.org/10.1038/ejcn.2015.84

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2015.84

Search

Quick links